Search Results - Tim Endy
- Showing 1 - 3 results of 3
-
1
Intracellular Cytokine Production by Dengue Virus–specific T cells Correlates with Subclinical Secondary Infection by Steven C. Hatch, Tim Endy, Stephen J. Thomas, Anuja Mathew, James Potts, Pamela Pazoles, Daniel H. Libraty, Robert V. Gibbons, Alan L. Rothman
Published 2011Artigo -
2
Characterising the benefits and risks of vaccines approved through accelerated pathways by Bethan Cracknell Daniels, Tim Endy, Joseph A. Lewnard, José Luis Di Fábio, Oscar Cortes-Azuero, Gabrielle Breugelmans, Simon Cauchemez, Alexander Roberto Precioso, Albert I. Ko, Rebecca E. Chandler, Stephen J. Thomas, Nicole Lurie, Henrik Salje
Published 2025Pré-impressão -
3
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines by Kirsten Vannice, Annelies Wilder‐Smith, Alan D.T. Barrett, Kalinka Carrijo, Marco Cavaleri, Aravinda de Silva, Anna P. Durbin, Tim Endy, Eva Harris, Bruce L. Innis, Leah C. Katzelnick, Peter G. Smith, Wellington Sun, Stephen J. Thomas, Joachim Hombach
Published 2018Artigo
Search Tools:
Related Subjects
Dengue fever
Dengue virus
Immunology
Medicine
Biochemistry
Biology
Business
Clinical trial
Cytokine
Dengue vaccine
Environmental health
Immune system
In vitro
Intensive care medicine
Licensure
Nursing
Pathology
Peripheral blood mononuclear cell
Population
Public health
Risk analysis (engineering)
Subclinical infection
Vaccination
Vaccine efficacy
Virology
Virus
Whole blood